Sai Life Sciences share price
You have to be logged in to add this to Watchlist.- ₹909.85(1.52%)December 15, 2025 15:54:17 PM IST
- NSE
- BSE
- Vol : 221.66 K (NSE + BSE)Last 20 day avg : 261.52 K
Sai Life Sciences is trading 1.52% upper at Rs 909.85 as compared to its last closing price. Sai Life Sciences has been trading in the price range of 913.50 & 898.20. Sai Life Sciences has given 19.73% in this year & 2.68% in the last 5 days. There are 4 analysts who have initiated coverage on Sai Life Sciences. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 83.84 Crores in its last quarter.Listed peers of Sai Life Sciences include Divi's Laboratories (-1.31%), Torrent Pharmaceuticals (0.07%), Sun Pharmaceutical Industries (-0.01%).The Mutual Fund holding in Sai Life Sciences was at 26.16% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Sai Life Sciences was at 22.49% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 15, 2025, 11:43 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.32The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,342.85 | -1.31 | 1,68,486.27 | 78.27 | 11.47 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 3,791.95 | 0.07 | 1,28,645.70 | 66.64 | 16.92 | 0.84 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,794.20 | -0.01 | 4,30,430.20 | 37.94 | 6.04 | 0.88 | 0.50 |
| Cipla | Bearish | 1,507.25 | -0.66 | 1,21,916.05 | 23.33 | 3.94 | 0.85 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,277.40 | -0.18 | 1,06,861.07 | 18.80 | 3.17 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-06 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-13 | Audited Results |
| 2025-02-06 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE570L01029
- BSE Code544306
- NSE CodeSAILIFE
Sai Life Sciences is trading at 909.85 as on Mon Dec 15 2025 10:24:17. This is 1.52% upper as compared to its previous closing price of 896.20.
The market capitalization of Sai Life Sciences is 19088.37 Cr as on Mon Dec 15 2025 10:24:17.
The average broker rating on Sai Life Sciences is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sai Life Sciences is 943.00 whereas the 52 wk low is 635.30
Sai Life Sciences can be analyzed on the following key metrics -
- TTM P/E: 61.67
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: 0.18
Sai Life Sciences reported a net profit of 170.13 Cr in 2025.
The Mutual Fund Shareholding was 26.16% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Sai Life Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.